Evaluation of critical parameters in the hollow‐fibre system for tuberculosis: A case study of moxifloxacin
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 01-09-2025
Project: ERA4TB
Updated at: 31-08-2024
Project: ERA4TB
Updated at: 31-08-2024
Project: ERA4TB
Updated at: 31-08-2024
Project: ERA4TB
Updated at: 31-08-2024
Project: ERA4TB
Updated at: 31-08-2024
Project: ERA4TB
Updated at: 31-08-2024
Project: ERA4TB
Updated at: 30-10-2023
Project: ERA4TB
Updated at: 30-10-2023
Project: ERA4TB
Updated at: 30-10-2023
Project: ERA4TB
Updated at: 30-10-2023
Project: ERA4TB
Updated at: 30-10-2023